Caxton Associates (New York)’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-100,000
Closed -$5.64M 222
2014
Q2
$5.64M Sell
100,000
-50,000
-33% -$2.64M 0.29% 68
2014
Q1
$7.88M Buy
+150,000
New +$7.46M 0.48% 47
2013
Q4
Sell
-200,000
Closed -$8.55M 251
2013
Q3
$8.55M Buy
+200,000
New +$7.81M 0.45% 59

Other funds holding HCA

Caxton Associates (New York)'s HCA Position: Q4 2024 in Review

Caxton Associates (New York) reduced its HCA Healthcare (HCA) stake by 34% in Q4 2024, selling an estimated $505K and leaving 2,844 shares worth $854K. The position accounts for 0.03% of the portfolio, ranked #244.

Caxton Associates (New York) first reported a position in HCA in Q4 2013 and has held it in 15 quarters since. The position peaked at $42.9M in Q4 2013. 1,181 funds tracked by Wall St. Rank hold HCA as of Q4 2024.

  • Caxton Associates (New York) held 2,844 shares of HCA Healthcare worth $854K as of Q4 2024.
  • Caxton Associates (New York) sold 1,444 HCA Healthcare shares in Q4 2024, an estimated $505K.
  • HCA Healthcare made up 0.03% of Caxton Associates (New York)'s portfolio in Q4 2024, its #244 holding.
  • Caxton Associates (New York) first reported a position in HCA Healthcare in Q4 2013 and has held it in 15 quarters since.
  • Caxton Associates (New York)'s HCA Healthcare position peaked at $42.9M in Q4 2013.
  • 1,181 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.